Trials / Active Not Recruiting
Active Not RecruitingNCT03077776
Tracking Triple-negative Breast Cancer Evolution Through Therapy
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 149 (actual)
- Sponsor
- UNICANCER · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective multicentre study which aims to examine the relationship between intratumour heterogeneity (ITH) and pathological response to neoadjuvant chemotherapy in patients with histological confirmation of triple-negative breast cancer (TNBC) who are eligible for neoadjuvant chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Biopsy | Biopsy of primary tumour to be performed prior to initiation of neoadjuvant chemotherapy |
| PROCEDURE | Biopsy (optional) | \[Optional\] biopsy of primary tumour to be performed after 4 weeks of neoadjuvant chemotherapy |
| PROCEDURE | Biopsy (metastatic) | Biopsy of metastatic site to be performed at the time of relapse |
Timeline
- Start date
- 2017-04-14
- Primary completion
- 2024-06-01
- Completion
- 2026-05-01
- First posted
- 2017-03-13
- Last updated
- 2025-02-20
Locations
10 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03077776. Inclusion in this directory is not an endorsement.